Presentation is loading. Please wait.

Presentation is loading. Please wait.

OCTOBER 2012 Interesting Case 1. 2 View the following cytology images and then think about your diagnosis. Slides 12 onwards provide the answer and follow.

Similar presentations


Presentation on theme: "OCTOBER 2012 Interesting Case 1. 2 View the following cytology images and then think about your diagnosis. Slides 12 onwards provide the answer and follow."— Presentation transcript:

1 OCTOBER 2012 Interesting Case 1

2 2 View the following cytology images and then think about your diagnosis. Slides 12 onwards provide the answer and follow up with corresponding histology

3 Case submitted by 3 Nick Dudding FIBMS, Advanced Biomedical Scientist Practitioner, Sheffield, UK. Assistant Director. East Pennine Cytology Training Centre. Callum Bowler FIBMS. Advanced Biomedical Scientist Practitioner. James Cook University Hospital. Middlesbrough. UK

4 Case history 4 67 year old Female. SurePath™ LBC sample Modified Papanicoloau staining All photomicrographs are x 400

5 5 Figure 1.

6 6 Figure 2.

7 7 Figure 3.

8 8 Figure 4.

9 9 Figure 5.

10 10 Figure 6.

11 What do you think this represents ? 11 Tissue repair Clear cell carcinoma Decidual change Squamous cell carcinoma Carcinosarcoma (mixed Müllerian carcinoma) The answer is on the next page

12 Answer 12 It is E Carcinosarcoma or mixed Müllerian carcinoma

13 Cytomorphology 13 Figure 1 shows one exfoliated ball of cells with slightly eccentric nuclear placement and prominent nucleoli. This would represent the carcinomatous elements. Figure 2 shows a single, but highly abnormal looking cell with multiple nucleoli contained within two enlarged nuclei. The remaining figures show a variety of enlarged or elongated cells, all with nucleoli, but also presenting with plentiful cyanophilic cytoplasm. These almost certainly represent the sarcomatous elements.

14 Histopathology 14 The uterus showed a high grade carcinosarcoma composed predominantly of sarcoma (Figures b – c) with rhabdomyoblasts and a minor component of serous adenocarcinoma (Figure a). The carcinosarcoma infiltrated a leiomyoma, but not the myometrium and hence is best regarded as FIGO IB. Focal vascular invasion was seen. The cervix, omentum and right and left ovaries and tubes showed no significant histological abnormalities.

15 15 Figure A.

16 16 Figure B.

17 17 Figure C.

18 Disease Fact Sheet 18 Malignant mixed Müllerian tumor, also known as malignant mixed mesodermal tumor, MMMT and carcinosarcoma, is a malignant neoplasm arising in the uterus. (1) Although MMMT can be picked up by cytology it generally presents in a postmenopausal patient being investigated for uterine bleeding, and found to have an enlarged uterus

19 Disease Fact Sheet 19 They are usually large, soft polypoid tumours occuring in the endometrium and myometrium. They are composed of a mixture of carcinomatous and sarcomatous elements. (2,3) The appearance of the sarcomatous elements divides the entity into two types, homologus and heterologous. In the homologous type, the sarcomatous component resembles tissues found in the uterus such as endometrial stromal sarcoma or leiomyosarcoma. In the heterologous type the sarcomatous element comprises tissues not found in the uterus, such as cartilage, skeletal muscle and/or bone.

20 Disease Fact Sheet 20 MMMT account for between two and five percent of all tumors derived from the body of the uterus, and are found predominantly in postmeonopausal women with an average age of 66 years.(4) Risk factors are similar to those of adenocarcinomas and include obesity, exogenous estrogen therapies, and nulliparity. Less well- understood but potential risk factors include tamoxifen therapy and pelvic irradiation (5)

21 Disease Fact Sheet 21 Outcome of MMMTs is determined primarily by depth of invasion and stage. As with endometrial carcinomas, the prognosis is influenced by the grade and type of the adenocarcinoma, being poorest with serous differentiation. MMMTs are highly malignant; a stage I tumor has an expected five-year survival rate of 50%, while the overall five-year survival rate is less than 20%. [5]

22 22 References 1. Barwick KW, Livolski VA. Malignant mixed Müllerian tumours of the uterus. Am J Surg Pathol 1979, 3: 125 – 135. 2. Silverberg SG, Major FJ,Blessing JA, Fetter B, Askin FB, Liao sy, Miller A. Carcinosarcoma (malignant mixed mesodermal tumour 3. A gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol1990, 9: 647 – 651. 4. Chuang JT, Van Velden DJJ, Graham JB Carcinosarcoma and mixed mesodermal tumour of the uterine corpus. Review of 49 cases. Obstet Gynecol 1970, 35: 769 -780. 5. Siegal GP; Chhieng DC (2005). Updates in diagnostic pathology. Berlin: Springer. pp. 12-14. ISBN 0-387-25357-2.


Download ppt "OCTOBER 2012 Interesting Case 1. 2 View the following cytology images and then think about your diagnosis. Slides 12 onwards provide the answer and follow."

Similar presentations


Ads by Google